The impact of chronic inflammation on long-term iron balance in women of reproductive age with Human Immunodeficiency Virus infection using iron isotope dilution method – A cohort study
Project Description
Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.
Project Duration
2023 - 2027
Project Lead
Dr. Shruthi Kulkarni
Authors
Dr. Shruthi Kulkarni
Project Status
ongoing
Project Type
International Atomic Energy Agency